Diagnosis and Treatment of Inflammatory Bowel Disease
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Gastroenterology & Hepatology".
Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 2244
Special Issue Editor
Special Issue Information
Dear Colleagues,
Though inflammatory bowel diseases (IBDs) have affected humans since time immemorial, they were described for the first time only in 1859, when Sir Samuel Wills used this term in a case report on ulcerative colitis. Then, in 1932, Crohn, Ginzburg and Oppenheimer published a series of 14 cases with "regional ileitis", which further contributed to the recognition of IBD as a common, and sometimes severe, disease impacting human health.
At present, several scientific societies, such as the European Crohn's and Colitis Organization (ECCO) and the Crohn's and Colitis Foundations of America (ccfa.org) and Canada (ccfc.ca) regularly publish guidelines on IBD diagnosis and treatment; however, the rapid development of new diagnostic and patient monitoring techniques and novel therapeutic possibilities (especially treatment with new biological agents), necessitates the publication of a Special Issue dedicated solely to IBDs.
Therefore, this Special Issue, ‘Diagnosis and Therapy of Inflammatory Bowel Diseases’ invites researchers, clinicians and administrators to submit their original articles, reviews, as well as case reports that describe novel diagnostic methods of IBD, propose algorithms for monitoring patients with IBD, highlights new data on the indications and sequencing of biological treatment in IBD, underscore the current indications of surgical treatment and the types of operations, and address a new treatment method in IBD, that is, diet therapy.
Potential topics include the following areas:
- Endoscopy in inflammatory bowel diseases, from diagnosis to treatment;
- Histopathologic diagnosis of inflammatory bowel diseases;
- Novel elements in differential diagnosis of inflammatory bowel diseases;
- Therapeutic monitoring of inflammatory bowel diseases;
- Therapy of moderate to severe Crohn’s disease;
- Therapy of moderate to severe ulcerative colitis;
- Diagnosis and treatment of pouchitis;
- Treatment of post-operative recurrence of Crohn’s disease;
- Role of diet therapy in maintaining remission of inflammatory bowel diseases in adults;
- Role of diet therapy in induction of remission of inflammatory bowel diseases in adults;
- Real-life data on the efficacy and safety of ustekinumab in Crohn’s disease in Romania;
- Case reports and literature reviews on paradoxical psoriasis in ustekinumab therapy.
Dr. Carmen Monica Preda
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ulcerative colitis
- Crohn’s disease
- inflammatory bowel diseases
- endoscopy
- histopathology
- therapeutic monitoring
- biologics
- infliximab
- adalimumab
- ustekinumab
- vedolizumab
- tofacitinib
- diets